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Abstract
OBJECTIVE: To monitor current production in
Qi-deficient liver cells, and to study how cellular
proton leakage might affect electric current pro-
duction.
METHODS: Cells were placed in an microbial fuel
cells (MFC) anode and the electric current was mea-
sured. Mitochondrial-affecting chemicals, 2,4-dini-
trophenol (DNP) and resveratrol (RVT), were used
to induce proton leakage in cells and their effect on
current production observed. MCF-7 breast cancer
cells exhibited higher proton leakage relative to
normal liver cells. A mouse model for Qi-deficiency
was prepared according to the Methodology of Ani-
mal Experiment in Chinese medicine. The Qi-tonics
Buzhongyiqi Tang (BZYQT), which is used to treat
the Qi-deficiency condition, was applied to Qi-defi-
cient liver cells to examine how current production
was altered.
RESULTS: Adding either DNP or RVT to normal liver
cells increased current production. MCF-7 cells that
possessed high proton leakage were also found to
produce higher currents than normal liver cells.
Higher current production, lower cellular glucose
content, and lower adenosine triphosphate (ATP)
production rate were found in Qi-deficient liver
cells, in which the use of DNP or RVT further in-
creased current production. The use of BZYQT to
treat Qi-deficient liver cells decreased current pro-
duction, counteracted the action of DNP, and also
improved cellular glucose content.
CONCLUSION: High electric current production
was found in liver cells with high cellular proton
leakage. Positive current responses to both mito-
chondria-affecting chemicals, DNP and RVT, ap-
peared to indicate proper mitochondrial function.
The high proton leakage detected in Qi-deficient
liver cells might have caused high energy losses,
which served to explain the observed lower cellular
glucose content and ATP production rate than in
normal cells. These results might also explain the
exhibited syndromes of low energy and fatigue in
Qi-deficient patients. Proton leakage, induced by
DNP or the Qi-deficient condition, was possibly
caused by unusual uncoupling of oxidative phos-
phorylation and appeared to be inhibited by treat-
ment with BZYQT, such that decreased current pro-
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duction was observed after BZYQT treatment.
© 2016 JTCM. All rights reserved.
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INTRODUCTION
A microbial fuel cell (MFC) is a device that utilizes the
respiratory metabolism of bacteria to produce electrici-
ty from various organic substrates.1 Catalytic oxidation
of organic substrates by bacteria at an anode releases
electrons that eventually reach the cathode via an exter-
nal electrical circuit, thus generating an electric cur-
rent. Most MFC studies have concentrated in the goal
of improving power output. Some of these devices
might be modified for applications in bioremediation,
as in MFC-based technologies to remove aqueous ni-
trate.2 However, there remains a lack of in-depth under-
standing of extracellular electron transport associated
with MFC operations. Although the exact mechanism
of electron transfer from cells to the anode is as yet un-
clear, it is quite clear that electrical energy is derived
from substrate metabolism via the respiratory metabo-
lism of bacterial cells.
Electric power from an MFC is limited by the problem
of over-potentials that hinder electron flow from bacte-
ria to the electrode and thus decreases the electric po-
tential across the MFC. These factors also include the
electrical resistances of the electrodes, membranes, and
electrolytes. Suboptimal contacts or low electrolyte con-
ductivity increase the internal resistance of an MFC
and decrease power generation.2 To keep variations in
internal resistance to a minimum, the same operating
procedure must be strictly followed in each experi-
ment. Any change incurrent measurement should then
reflect cellular biochemical changes.
During respiratory metabolism in organisms, protons
and electrons are produced in the mitochondrial elec-
tron transport chain (ETC). Hydrogen ions are
pumped from the matrix, across the inner membrane,
and into the intermembrane space, which creates a
high inner membrane potential. This high proton-mo-
tive force drives protons across the inner membrane
back into the matrix via adenosine triphosphate (ATP)
synthase, which converts adenosine diphosphate to
ATP.3 However, the fact is that not all hydrogen ions
flow through ATP synthase from the inner membrane,
as some of them escape in an earlier ETC step. This un-
coupling phenomenon between electron transfer and
ATP synthesis is termed proton leakage, which leads to
reduced ATP production.4 Some energy that are lost be-
cause of proton leakage is released as heat to the sur-
roundings and accounts for 20%-30% of heat genera-
tion by basal metabolism.5
As the degree of cellular proton leakage relates the loss
of protons and electrons from the cell, it is reasonable
to hypothesize that the degree of proton leakage might
improve extracellular electron transport and reduce ac-
tivation losses for electricity production.2 To confirm
the involvement of proton leakage during ETC in mi-
tochondria with electric current production by cells,
different cells with different degrees of proton leakage
conditions, including normal liver cells, and high pro-
ton leaking cancer cells can be used in experiments to
study the relationship between proton leakage and elec-
trical measurements in an MFC. Proton leakage
through various mechanisms can be induced by select
chemicals, including resveratrol (RVT) and 2,4-dinitro-
phenol (DNP). RVT increases the mitochondrial mem-
brane potential by inhibiting ATP synthase activity in
a dose dependent manner,6 leading to increases in cellu-
lar proton leakage. DNP increases proton leakage by
enhancing proton conductivity across the mitochondri-
al inner membrane7 and mild uncoupling of oxidative
phosphorylation.8
As low energy generation and metabolism9 have been
described in Qi-deficiency of Traditional Chinese Medi-
cine (TCM), it would be of great interest to examine
how the low energy status of such cells affects current
generation in an MFC. Qi in TCM has been described
to be related to energy metabolism, in which ATP
plays an important role.3 During respiratory metabo-
lism, bioenergy in the form of ATP is generated via gly-
colysis, the citric acid cycle, and the ETC. The final
step of the ETC provides the most ATP, ~90%, to the
cell. Thus, it is reasonable to hypothesize that Qi might
relate to the ETC in the human body and Qi tonics,
for treating Qi deficiency, might exert their effect on
the process. Therefore, the mouse model of Qi-deficien-
cy in TCM was used here to improve the understand-
ing of the relationship between electric current genera-
tion and low energy metabolism of cells.
METHODS
Materials and reagents
All chemicals used in experiments were at analytical
grade (China). Hepes was purchased from Yuanye
Bio-Technology Co., Ltd. (Shanghai, China); collage-
nase IV and percoll from Biosharp Co., Ltd. (Heifei,
China); the protonophore 2,4-dinitrophenol (DNP)
and ATP inhibitor resveratrol (RVT) from Sigma-Al-
drich, Inc. (St. Louis, MO, USA). Fifty milligrams of
RVT or DNP were dissolved into 10 mL of ethanol to
obtain 5000 ppm stock solutions. Then, 2 mL of each
stock was diluted to 10 mL using perfusion buffer to
produce 1000 ppm solutions.
Preparation of buffers and Chinese medicine
Perfusion buffer concentrate (PBC): NaCl (103.75g),
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KCl (6.25g, Sigma-Aldrich, Inc.), and hepes (28.70 g,
Biosharp Co., Ltd.,) dissolved in water followed by the
addition of 1 M NaOH (75 mL). Water was then add-
ed to a final 500 mL volume.
Perfusion buffer: 40 mL of PBC diluted up to 1 L and
then autoclaved before use.
Preservation buffer: 2.5 g of bovine serum albumin
(BSA; Yuanye Bio-Technology Co., Ltd.,) were added
to 250 mL of perfusion buffer and then stored at +4 ℃
or in an ice bath.
Dissociation buffer: 0.5 mL of 476 mM CaCl2was add-
ed to 49.5 mL of perfusion buffer to a final concentra-
tion of 4.76 mM CaCl2. Three mg of collagenase
(Biosharp Co., Ltd.,) was added just before starting per-
fusion.
50% percoll and 25% percoll: 1.5 mL of 10 × PBS was
added to 13.5 mL of stock percoll to yield 100% per-
coll. 10 mL of 100% Percoll was then mixed with 10
mL of PBS to produce 50% percoll, and 5 mL of
100% Percoll was mixed with 15 mL PBS to yield
25% Percoll.
Buzhongyiqi Tang (BZYQT):10 BZYQT is a Qi-tonic
used to treat Qi-deficiency in TCM.10 The formula for
BZYQT was Huangqi (Radix Astragali Mongolici) 18 g,
Gancao (Radix Glycyrrhizae) 9 g, Renshen (Radix Gin-
seng) 6 g, Danggui (Radix Angelicae Sinensis) 3 g, Chen-
pi (Pericarpium Citri Reticulatae), 6 g, Shengma (Rhi-
zoma Cimicifugae Foetidae) 6 g, Chaihu (Radix Bupleu-
ri Chinensis) 6 g, Baizhu (Rhizoma Atractylodis Macro-
cephalae) 9 g. All of these TCM materials were pur-
chased from China Resource Sanjiu Medical & Phar-
maceutical Company (Shenzhen, China). The weight
of the BZYQT extract (8 g) was dissolved in 250 mL
of deionized water to prepare a stock solution of 252 mg
of dry weight extract/mL.
Mouse model of Qi-deficiency
Healthy mice (Kunming mice, males, good health,
18-22 g were used to set up a Qi-deficiency model ac-
cording to the Methodology of Animal Experiment in
Chinese Medicine.11 The animal study was approved
by the research ethics committee of Shanghai Jiao Tong
University affiliated Sixth People's Hospital South
Campus (Shanghai, China). The mice were randomly
divided into two groups, a normal and a Qi-deficiency
group. The mice of the normal group or Qi-deficiency
group were required to stand individually on platforms
floating on water. The platforms for the normal group
were 6 cm, which allowed the mouse to rest, while the
platforms for Qi-deficiency group were 2 cm, which
made it difficult for the mouse to rest. The mice were
required to stand on the platforms twice a day for 15 day
and 30 min each time. After 15 d, posterior pituitary
extract (6 U/1 mL, 0.17 mL/mouse) was injected into
each Qi-deficiency group mouse after the last standing,
while the same volume of saline (0.9% NaCl by wt)
was injected into each normal group mouse. The suc-
cess of the mouse model was tested by measuring the
animals' sleeping time after IP sodium pentobarbital in-
jection (2% by wt, 45 mg/kg of animal).11
After the mice had developed Qi-deficiency, liver cells
were obtained after the animals were anesthetized with
ethyl ether and then dispatched by cutting the dia-
phragm. This animal study was approved by the re-
search ethics committee of Shanghai Jiao Tong Univer-
sity affiliated Sixth People's Hospital South Campus.
Qi-tonic, a preparation that can improve Qi-deficiency
was also used in experiments to extend the understand-
ing of the relationship of electric current generation
and low energy cellular metabolism.
Preparation of mouse liver cells
Mouse liver cells were prepared according to the meth-
od used by Smedsrød.12 After the mice were anesthe-
tized with ethyl ether, the mouse was opened to expose
the peritoneal cavity and then the portal vein located.
Perfusion buffer (30 mL) was perfused into the portal
vein, followed by perfusion with dissociation buffer
(50 mL). The perfused liver was then removed from
the body and placed in an aseptic petri dish with pres-
ervation buffer. Gall bladder was also carefully re-
moved and the cells released into preservation buffer.
The liver-cell solution was then centrifuged four times
under different conditions. The liver cell solution was
first centrifuged at 54 × g and 4 ℃ for 2 min and the
supernatant then centrifuged at 54 × g and 4 ℃ for 2
min. Next, the collected supernatant was centrifuged at
1350 × g and 4 ℃ for 10 min. Thirdly centrifuged at
1350 × g for 10 min at 4 ℃. Sediments were collected
by pouring out the supernatant, then added with 10 mL
preservation buffer to re-suspend all the sediments in a
50 mL centrifuge tube. Load on top of 25 / 50% Per-
coll gradient. Finally, the solution was centrifuged at
1350 × g for 30 min at 4 ℃ . Non-parenchymal cells
(NPC) were collected from the interface between the
two density cushions of 25% with 50% Percoll with a
1ml pipette into a conical flask with 50 mL preserva-
tion buffer. A small amount of cell solution (1 mL for
each) was collected for ATP and glucose experiments.
An aliquot of original liver cell solution (25 mL) was
diluted with preservation buffer (75 mL) and placed in
four Erlenmeyer flasks for the next MFCs experiments.
MCF-7 breast cancer cells
MCF-7 breast cancer cells13 were cultured at 37 ℃ for
two days in DMEM (Fisher Scientific UK, Ltd.,
Loughborough, UK) with 10% Fetal Bovine Serum
(FBS) and 1% penicillin before the cells were washed
with 2 mL of PBS. The washed cells were then treated
with trypsin for resuspension in PBS and frozen at －
80℃ before use.
MFC experiments
Potassium hexacyanoferrate (Ⅲ) (C6N6FeK3; Sinopharm
Chemical Reagent Co., Ltd., Shanghai, China) at 50
mM was used in MFCs as the cathode electrolyte solu-
tion to provide a high concentration of readily avail-
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able electron acceptors. Each set of MFC apparatus
contained a cathode and anode. Potassium hexacyano-
ferrate (Ⅲ) (100 mL at 50 mM) was placed in the cath-
ode and the liver cell solution (100 mL), at the same
cell concentration for all groups, was placed in the an-
ode. A digital multi-meter (DMM 4020 5-1/2 Digital
Multi-meter, Tektronix, Inc., Beaverton, OR, USA)
was used to detect voltage and current changes.
Nitrogen gas was pumped into the anode-containing
cell for 5 min to flush out oxygen gas and before the
voltage EMFC across the two electrodes was monitored.
The presence of oxygen reduces current production by
prematurely binding electrons before reaching the cath-
ode via the anode. However, the absence of oxygen pos-
es a survival challenge for liver cells in an MFC, and
dissolved oxygen in the medium only allowed an exper-
iment to be performed over a short time period. The
survival rate of liver cells after 60 min in an MFC was
monitored by staining with trypan blue (0.4% , w/v).
Dead cells were stained blue, while living cells re-
mained transparent. The numbers of living and dead
cells were counted under a microscope using a hemocy-
tometer.
After an MFC system was stabilized for half an hour,
DNP (500 mL at 1000 ppm), RVT (500 mL at 1000
ppm), or BZYQT (100 mL at 252 µg dry wt/mL) was
added to the cell chamber. The open circuit voltage, EM-
FC, across the two electrodes was monitored for another
30 min. Under the same operating conditions, the
MFC internal resistance was assumed to remain the
same. The electric current was calculated based on the
external resistance, Rext, of 2000 W by the following
equation (I, current).
EMFC = I∙Rext
The 20-min current value, before addition of a perturb-
ing chemical, was used as the baseline, and the current
change calculated by subtracting the 20-min current
baseline value from the 20-min value after chemical ad-
dition. Quantitative data were expressed as mean ±
standard error. T-tests with paired groups were per-
formed using Excel for parameter comparison between
groups. A P value of < 0.05 was considered statistically
significant.
Determination of glucose
A glucose oxidase method was used to determine glu-
cose concentrations (Applygen Technologies, Inc., Bei-
jing, China).
Determination of ATP
ATP determinations were performed using a EN-
LITEN® ATP Assay System Bioluminescence Detec-
tion Kit for ATP Measurement (Promega Corp., Madi-
son, WI, USA) and an ATP Bioluminescence Assay to
Quantify Cell Cytotoxicity (BMG LABTECH
GmbH, Ortenberg, Germany), following manufactur-
er' s instructions. A FLUOstar Omega fluorescence mi-
croplate reader (BMG LABTECH GmbH) was used
to measure luminescence.
RESULTS
Establishment of a mouse model for Qi-deficiency
After a 15-day treatment, the hairs on Qi-deficient
mice were loose and bodyweight sand sleeping times af-
ter pentobarbital injection were lower and shorter
[(29.0 ± 1.7) g and (21.3 ± 0.3) min, respectively) than
the normal mice [(34.6 ± 2.4) g, (27.7 ± 1.4) min, re-
spectively]. These results indicated the successful estab-
lishment of a mouse model for Qi-deficiency.11
Cellular glucose concentration
The cellular glucose concentration of Qi-deficient cells
at (29.5 ± 10.8) µM was found to be significantly low-
er than that of the normal at (84.8 ± 14.0) µM. Qi-ton-
ics BZYQT, used to improve the Qi-deficiency condi-
tion, were found to slightly improve the glucose con-
centration of Qi-deficient liver cells [(49.5 ± 14.7)
µM] but not normal cells [(77.8 ± 28.5) µM].
Changes in ATP concentration after 30 min of
treatment with BZYQT
The present results indicated that the 30-min change
in ATP concentration observed in the normal group af-
ter adding water was found to be positive, while the
change was negative in the Qi-deficient group. Similar
results were found for ATP content after BZYQT addi-
tion for 20 min. Negative values indicated that the
ATP utilization rate exceeded the production rate un-
der these experimental conditions. The 20-min expo-
sure to BZYQT did not improve the condition of
Qi-deficient cells.
Electric current production from liver cells measured
by MFC
The survival rate of liver cells was estimated to be
72.5% after 60 min in an MFC. Figure 1 shows the
current change (µA) in normal liver cells under differ-
ent chemical treatments at the same cell concentration.
The current change was calculated by subtracting the
current value measured after chemical addition from
the baseline value. Both DNP and RVT were found to
produce positive current changes in normal liver cells
with different increasing modes. DNP produced posi-
tive current changes with a high initial value that then
decreased with time. RVT produced positive current















0 5 10 15 20
Nomal liver cells
RVT to normal liver cells
DNP to normal liver cells
MCF-7
Time (min)
Figure 1 Changes in electric current (mA) with time (min) of
cells under different treatments
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cells showed higher positive current changes than that
of the normal liver cells.
Figure 2 shows the increases in current change (µA) in-
duced by DNP or RVT with Qi-deficient liver cells.
These cells were found to have higher positive current
changes than normal cells (Figures 1 and 2). Applica-
tion of either DNP or RVT further increased the cur-
rent output from Qi-deficient liver cells.
Qi-tonics BZYQT did not significantly affect the cur-
rent output from normal liver cells (Figure 3), while it
did decrease the current output of Qi-deficient liver
cells. The effects of DNP on BZYQT-pretreated nor-
mal cells were minimal (Figure 4), and BZYQT treat-
ment was found to counteract the action of DNP on
Qi-deficient liver cells (Figures 2 and 4). RVT addi-
tion to BZYQT-pretreated normal or Qi-deficient liv-
er cells further increased the positive current changes
(Figure 5).
DISCUSSION
Proton leakage has been implicated in various diseased
conditions, including cancer, diabetes, aging, and obesi-
ty.14 Generally, proton and electron leakage are mea-
sured and calculated indirectly using oxygen consump-
tion methods with isolated mitochondria.15 In the pres-
ent study, an MFC was used to measure the current
change from intact cells and correlate it with their pro-
ton leakage conditions. The benefit of using whole
cells in these measurements allowed instantaneous re-
sponses from cells, which could aid in the development
of new therapeutic regimes.
In this present study, MFCs were successfully used to
measure electric current changes from whole mouse liv-
er cells, while cell survival was maintained at 72.5% af-
ter 60 min in an MFC. The circuit of an MFC was
completed by proton leakage from cells, with passage
from the anode across the inter-chamber proton ex-
change membrane to the cathode. Electrons reached
the anode via an external circuit to the cathode. The
current, I, in the external circuit could be calculated
from the open circuit voltage, EMFC, measured across
the two electrodes, by dividing it by the external resis-
tance Rext. The effect of added perturbing chemicals
was evaluated by changes in the MFC electric current.
MFC measurements are influenced by a number of fac-
tors that contribute to the loss of voltage and generated
power. Voltage loss is contributed by four factors, in-
cluding activation loss for electron transport from cells
to the anode, cellular metabolism, reactant flux to the
electrode, and ohmic losses.2 Activation loss and cellu-
lar metabolism are more cell-specific, while reactant
flux to the electrode and ohmic losses are contributed
more by the equipment, including the electrical resis-
tance of the electrodes, membrane, and electrolyte in
anMFC.2 Poor contacts of low conductivity by the elec-
trolyte increase the internal resistance over the MFC
and affect MFC measurements.2 Here, experimental
conditions were strictly maintained to minimize the in-
fluence of internal resistance variations on measure-
ments. The observed induced changes incurrent pro-
duction from cells induced by perturbing chemicals
probably reflected biochemical changes in the affected
cells.
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Figure 2 Changes in electric current (mA) with time (min) of
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Figure 5 Changes in electric current (mA) with time (min) of
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Figure 3 Changes in electric current (mA) with time (min) of
liver cells under different treatments
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cal process for electricity production from bacteria and
cells. Factors affecting ETC processes might alter the
activation losses for electron transport from cells to the
anode,2 which would then change the measured cur-
rent magnitude. Both DNP and RVT increased cellu-
lar proton leakage and were found to produce positive
current changes in normal liver cells. The degree of pro-
ton leakage is significantly influenced by uncoupling of
oxidative phosphorylation, proton conductivity, and
the mitochondrial membrane potential.15 DNP increas-
es proton conductivity across the inner membrane7 and
induces mild uncoupling of oxidative phosphorylation,8
thusproducinghigh positive current changes immediate-
ly after chemical addition, with an observed initially
high value. The sudden increase in proton conductivity
allowed a high number of protons to leak from cells at
the same time, which contributed to high current and
voltage magnitudes .However, positive current changes
induced by DNP then gradually declined with time,
which indicated a drop in the external circuit and a
proton depletion status in cells over time. RVT inhibit-
ed ATP synthase and thus increased the mitochondrial
membrane potential. Such increases in mitochondrial
membrane potential might require time to accomplish
and, as a result, the positive current changes with RVT
were found to increase gradually with time.
Cancer cells have been reported to have high proton
leakage, which is probably due to the upregulation of
UCP2 protein,16 particularly in drug-resistant cancer
cells.17 The high energy losses from proton leakage are
compensated for by biochemical re-engineering, which
has been observed in cancer cells, to produce enhanced
glycolysis to increase ATP production.18 High metabol-
ic rates in cancer cells18 further induces proton leakage,
which contributes to high current production in these
cells.
According to the Methodology of Animal Experiments
of Chinese medicine, a mouse model for Qi-deficiency
was established here. The success of the model was sup-
ported by the lower body weights and shorter sleeping
times after IP pentobarbital injections.11 The concept
of Qi in traditional Chinese medical theory relates to
energy generation and metabolism,9 in which ATP
plays an important role.3 In this study, Qi-deficient liv-
er cells were found to have lower cellular glucose con-
tent than normal cells. The negative value of the 30-mi-
nATP concentration change also indicated that the
ATP utilization rate exceeded the production rate, which
might imply a lower ATP production rate in Qi-defi-
cient liver cells. Observations of both lower cellular glu-
cose contents and lower ATP production rates in
Qi-deficient liver cells were consistent with traditional
Chinese medical theory regarding the Qi-deficient con-
dition with syndromes of fatigue and lack of energy.9
Qi-deficient liver cells were found to produce higher
positive current changes than normal cells, which were
slightly increased even more by DNP or RVT. These re-
sults indicated that the high positive current change in
Qi-deficient liver cells might have been caused by high
proton leakage leading to decreased cellular ATP pro-
duction and energy loss. Cellular energy loss in cells
could have contributed to the exhibited Qi-deficient
syndrome of low energy and fatigue. Lower ATP pro-
duction would also affect the gluconeogenesis rate and
thus decrease cellular glucose content. This was consis-
tent with the present observations of lower cellular glu-
cose contents and ATP production rates in Qi-defi-
cient cells.
Qi-tonics BZYQT used to treat Qi-deficiency appeared
to alleviate positive current changes, while it showed
no effects on normal liver cells. Addition of RVT to
BZYQT-treated normal cells or Qi-deficient cells fur-
ther increased current production, probably by increas-
ing the mitochondrial membrane potential that then
induced proton leakage. However, DNP was found to
lose its action in BZYQT-treated normal cells, and
BZYQT counteracted the effect of electric current in-
crease by DNP in Qi-deficient cells. These actions by
BZYQT were suggested to be the blocking of unusual
uncoupling of oxidative phosphorylation, e.g., induced
by DNP, or the sub-health conditions of Qi-deficiency.
Normal oxidative phosphorylation processes did not
appear to be affected by BZYQT, and thus, no change
was observed in current production in BZYQT-treated
normal cells.
Using MFCs, electric current was successfully mea-
sured from intact cells under different conditions,
which were found to correlate with their proton leak-
age status. Cancer cells and Qi-deficient cells were
found to exhibit higher proton leakage than normal
cells, with higher positive current changes measured by
MFC. High proton leakage in Qi-deficient cells in-
creased energy losses, which led to lower cellular glu-
cose content as well as cellular ATP production rate.
This was consistent with the exhibited syndrome of
low energy and fatigue described for Qi-deficient pa-
tients. BZYQT alleviated increases in current produc-
tion in Qi-deficient liver cells, probably by blocking un-
usual uncoupling of oxidative phosphorylation in-
duced by DNP or the condition of Qi-deficiency. The
use of MFCs to monitor the proton leakage status was
quick and simple and could serve a valuable tool for fu-
ture drug development efforts.
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